Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)
Hong Kong · Delayed Price · Currency is HKD 5.48
+0.05 (0.92%)
Jul 31, 2026, 4:08 PM HKT
HKG:2576 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 512.54 | 512.54 | 551.16 | 573.14 | 549.22 | 466.18 |
Revenue Growth | -1.92% | -7.01% | -3.84% | 4.36% | 17.81% | 53.88% |
Gross Profit Gross Profit Growth | 217.54 | 217.54 | 224.94 | 179 | 185.4 | 164.33 |
Operating Income Operating Income Growth | -57.23 | -57.23 | -265.05 | -401.4 | -485.44 | -462.59 |
Net Income Net Income Growth | -42.85 | -42.85 | -214.61 | -346.78 | -412.91 | -479.61 |
Earnings Per Share EPS Growth | -0.08 | -0.08 | -0.39 | -0.64 | -0.77 | -0.89 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Mainland China Mainland China Growth | 497.87 | 497.87 | 522.09 | 567.57 | 545.01 | 464.48 |
The United States The United States Growth | 6.49 | 6.49 | 0.93 | - | - | - |
Singapore Singapore Growth | 3.46 | 3.46 | 20.03 | 0.9 | 0.63 | 0.31 |
Korea Korea Growth | 1.77 | 1.77 | 5.3 | 2.72 | 1.26 | - |
Others Others Growth | 2.96 | 2.96 | 2.8 | 1.96 | 0.32 | 0.22 |
Total Total Growth | 512.54 | 512.54 | 551.16 | 573.14 | 549.22 | 466.18 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,192 | 1,192 | 1,199 | 1,068 | 1,408 | 1,400 |
Total Debt Total Debt Growth | 61.13 | 61.13 | 34.76 | 15.09 | 45.86 | 77.44 |
Net Cash (Debt) Net Cash Growth | 1,131 | 1,131 | 1,165 | 1,053 | 1,362 | 1,322 |
Net Cash Growth | 0.03% | -2.91% | 10.61% | -22.69% | 3.01% | -17.63% |
Net Cash Per Share Net Cash Per Share Growth | 2.01 | 2.01 | 2.14 | 1.96 | 2.53 | 2.46 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -39.38 | -39.38 | -201.62 | -351.16 | -329.22 | -217.53 |
Capital Expenditures CapEx Growth | -3.04 | -3.04 | -5.68 | -4.36 | -24.4 | -30.1 |
Free Cash Flow Free Cash Flow Growth | -42.43 | -42.43 | -207.3 | -355.52 | -353.62 | -247.63 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.44% | 42.44% | 40.81% | 31.23% | 33.76% | 35.25% |
Operating Margin | -11.16% | -11.16% | -48.09% | -70.04% | -88.39% | -99.23% |
Pretax Margin | -9.89% | -9.89% | -39.45% | -62.18% | -76.94% | -102.88% |
Profit Margin | -8.36% | -8.36% | -38.94% | -60.50% | -75.18% | -102.88% |
FCF Margin | -8.28% | -8.28% | -37.61% | -62.03% | -64.39% | -53.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 102.92 | - | - | - | - |
PS Ratio | 5.42 | 3.91 | 4.11 | - | - | - |